Observational studyPloS one2025

Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort.

Yoshiyuki Yokomaku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.